Factor VIII and von Willebrand Factor — Drug Target

All drugs that target Factor VIII and von Willebrand Factor — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Coagulation factor concentrate

Marketed (1)

• Plasma-derived FVIII/VWF concentrate · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Coagulation factor concentrate · Hematology
  This plasma-derived concentrate replaces deficient Factor VIII (FVIII) and von Willebrand Factor (VWF) to restore blood clotting ability in patients with hemophilia A or von Willebrand disease.